Navigation Links
LVAS in Medical News
Thoratec Schedules Second Quarter Conference Call, Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te......sity of Michigan and Columbia University Medical Center. The DuraHeart lvas is part of a new, third-generation class of artificial mechanical support t... death due to end-stage left ventricular failure. “The DuraHeart lvas is an important technological advancement in the field of mechanical circul...
Thoratec Announces Appointment of Paul LaViolette to Board of Directors
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...Thoratec Presentation at JMP Securities Conference to be Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Thoratec Schedules First Quarter Conference Call, Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
...erapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...Thoratec Presentation at Raymond James Conference to Be Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
... commercially approved cardiac assist devices including the HeartMate II(R) lvas (Left Ventricular Assist System), which received U.S. approval for bridge-t...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 12,000 devices implanted in patients suffering from heart fa...Thoratec Reports 34 Percent Increase in 2008 Revenues
...highlighted by the successful U.S. commercial launch of our HeartMate II(R) lvas (Left Ventricular Assist System) for bridge-to-transplantation (BTT) and th...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in...Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni...LVAS in Medical Technology
Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
ANN ARBOR, Mich., April 28 /PRNewswire/ -- Terumo Heart, Inc. announced a presentation at the recent ISHLT meeting in Boston. The presentation entitled "Long Term Circulatory Support with the DuraHeart(TM) Mag-Lev Centrifugal LVAS for Advanced Heart Failure Patients Eligible for Transplantatio...DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
ANN ARBOR, Mich., March 3 /PRNewswire/ -- Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication. (Logo: ht...Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
ANN ARBOR, Mich., Sept. 17 /PRNewswire/ -- Terumo Heart, Inc. announced today that it had a successful European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland. (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ) ...ANN ARBOR, Mich., Sept. 6 /PRNewswire/ -- Terumo Heart Inc. announced today that it is planning a European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland on September 17, 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/2006102...
...ccessful ongoing global expansion of the DuraHeart lvas program, the distinction for the 100th implant cam...e a very good quality of life." The DuraHeart lvas is the first, third-generation rotary blood pump d...le minimizing device wear and tear. The DuraHeart lvas is currently being studied in the DuraHeart Pivota...
...n therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) divisio...
Discharge of First U.S. DuraHeart(TM) Patient
...ional Co-Principal Investigator for the U.S. pivotal trial of the DuraHeart lvas commented on the recent discharge. "We are extremely pleased with the perfo...nd mechanical failure. Significant advances have been made in the DuraHeart lvas to potentially overcome these problems. Dr. Nojiri explained: "We have a un...First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
... 2008, patient support averaged 223 days with cumulative support of 43 years. The longest ongoing patient support is over three years. The DuraHeart lvas Pivotal Trial is a multi-center, prospective, non- randomized study of 140 patients and will include up to 40 centers. The device is intended to provi......proval is the final step to initiate the DuraHeart lvas U.S. Pivotal Trial following the completion of sta...art, Inc., said, "With the IRB approval, DuraHeart lvas will be the first third-generation centrifugal pum...s team on the U.S. Pivotal Trial." The DuraHeart lvas Pivotal Trial is a multi-center, prospective, non-...
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
... PMA (PreMarket Approval) application, allowing the use of its HeartMate II lvas (Left Ventricular Assist System) as a bridge-to-transplantation (BTT) in pa...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 11,000 devices implanted in patients suffering from heart fa...LVAS in Medical Products
Description: VentrAssist is a new third generation cardiac assist system primarily designed as a permanent alternative to heart transplants for patients suffering heart failure.
It is a blood pump that connects to the left ventricle of the diseased heart to help the ailing hearts pumping function and assi...
Company:Ventracor Inc.
Description: WorldHeart's Novacor LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. Novacor LVAS has been implanted in more than 1,500 patients, and is the first mechanical circulatory support device to support a single pati...
Company:World Heart Corporation
Description: There are two versions of the HeartMate Left Ventricular Assist System (LVAS): the Vented Electric (XVE) LVAD, which is powered by wearable batteries that allow the patient to be mobile, and the Implantable Pneumatic (IP), which is powered by an external Drive Console. Both devices are fully implan...
Company:Thoratec
Description:... to restore hemodynamic function and improve patient outcomes and quality of life. Through the rotary action of a single-moving part, the HeartMate II lvas can achieve long-term full circulatory support by pumping blood from the heart to the body at up to 10 liters per minute....
Company:Thoratec
Company:Arrow International, Inc.
Company:Ventracor Inc.
Description: WorldHeart's Novacor LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. Novacor LVAS has been implanted in more than 1,500 patients, and is the first mechanical circulatory support device to support a single pati...
Company:World Heart Corporation
Description: There are two versions of the HeartMate Left Ventricular Assist System (LVAS): the Vented Electric (XVE) LVAD, which is powered by wearable batteries that allow the patient to be mobile, and the Implantable Pneumatic (IP), which is powered by an external Drive Console. Both devices are fully implan...
Company:Thoratec
Description:... to restore hemodynamic function and improve patient outcomes and quality of life. Through the rotary action of a single-moving part, the HeartMate II lvas can achieve long-term full circulatory support by pumping blood from the heart to the body at up to 10 liters per minute....
Company:Thoratec
LionHeart Left Ventricular Assist System (LVAS)
Description:...s with progressive, irreversible, end-stage (Class IV) congestive heart failure, for which heart transplantation is not an option. The Arrow LionHeart lvas is not intended as a bridge to transplant or as a bridge to recovery of ventricular function. It is a therapeutic option for patients who are ineligib...Company:Arrow International, Inc.
LVAS in Biological Technology
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
... of Destination Therapy (DT) for the HeartMate II lvas (left ventricular assist system). The HeartMate II...anced-stage heart failure patients. An implantable lvas powered by a rotary pumping mechanism, the HeartMa...c(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 13,000 devices implanted in patient...Thoratec Presentation at J.P. Morgan Conference to be Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni...Thoratec Reports 44 Percent Increase in Third Quarter Revenues
...ancial performance was driven by the continued adoption of the HeartMate II lvas (Left Ventricular Assist System) for bridge-to-transplantation, which helpe...lure. The company's product lines include the Thoratec(R) VAD and HeartMate lvas with nearly 12,000 devices implanted in patients suffering from heart failu...Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni......scular Division, where quarterly revenues grew 11 percent year-over-year. This growth primarily reflects the continued adoption of the HeartMate II(R) lvas (Left Ventricular Assist System) in both Europe and through our U.S. clinical program. In addition, fourth quarter revenues at our International Techn...
Thoratec Presentation at JP Morgan Conference to be Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Thoratec Announces Appointment of Steven H. Collis to Board of Directors
...eloping products to treat cardiovascular disease. The company's product line includes the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Thoratec Presentation at Bear Stearns Conference To Be Webcast
...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
...n therapies to address advanced stage heart failure. The company's product lines include the Thoratec VAD(R) (Ventricular Assist Device) and HeartMate lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...Other TagsOther Contents
(Date:6/17/2013)... 2013 The Woodstock Fruit Festival is proud ... Festival this summer, which will be held in Diamond Point, ... , Blake professes the benefits he's received by regularly ... fuel his world class sprinting abilities. Fruit is commonly considered ... drawing attention. "Yohan Blake believes in the power of natural ...
(Date:6/17/2013)... 2013 MelanSol® All Natural Skin Care ... the US distributor for MelanSol®, has partnered with the ... Food Bank to support their efforts to feed ... that they receive a portion of every sale of ... Moisturizer. Contributions will be given on sales from ...
(Date:6/17/2013)... A team from the New York Stem Cell ... Center of Columbia University has generated patient-specific beta cells, ... maturity-onset diabetes of the young (MODY). , The ... induced pluripotent stem (iPS) cells, from which they then ... cell-derived beta cells secreted insulin in a manner similar ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a ... has recently undergone a mainstream culture explosion. Interpretation of the ... Surgery, they regard the term to mean a combination of ... of the effects of pregnancy on a woman’s body. ... the breast with gain or loss of volume, widening of ...
(Date:6/17/2013)... pyrvinium pamoate inhibits aggressive forms of prostate cancer that ... conducted in an animal model. The results will be ... in San Francisco. , "Our novel prostate cancer drug ... lead author Jeremy Jones, PhD, assistant professor of molecular ... Duarte, CA. "Thus, it has the potential to treat ...
Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2[0] Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor[0] All Natural Sunscreen Fights Hunger[0] NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes[0] Tarrant Plastic Surgery Announces Summer Makeover Special[0] New medication treats drug-resistant prostate cancer in the laboratory
(Date:6/17/2013)... Women in the U.S. exposed to high levels of ... to have a child with autism as women who lived ... from Harvard School of Public Health (HSPH). It is the ... air pollution across the U.S. , "Our findings raise concerns ... women in our study lived in areas where risk of ...
(Date:6/17/2013)... locations with central nervous system infections may well be ... according to a study to be published in ... Society for Microbiology. Researchers have detected the virus in ... central nervous system infections of unknown cause, and in ... pigs and poultry, suggesting animals may serve as reservoirs ...
(Date:6/17/2013)... virus in patients with severe brain infections in Vietnam. ... is responsible for the symptoms of disease. , The ... of 644 patients with severe brain infections in the ... of the 122 patients with non-infectious brain disorders that ... nervous system are often fatal and patients who do ...
Breaking Biology News(10 mins):Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |